Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Germany's Upper House Adds Weight To Urgent Calls To Address EU MDR/IVDR Issues

Executive Summary

The German Parliament’s Upper House wants the government to intervene when it comes to the patchy implementation of the EU's medtech regulations and slow the rapid disappearance from the market of safe medtech products at the same time as maintaining the German medtech sector.

You may also be interested in...



French Government Will Tell Commission To Give Notified Bodies Time To Process All Files

Despite proposals to alleviate the threat of medtech products being unnecessarily removed from the EU market when their old certificates expire, concerns remain at the highest level and calls for action persist.

MDCG Listens To Industry Over New Medtech Regulation Hurdles And Publishes 19-Point Action Plan

The medtech sector will be relieved to see this latest document relating to the implementation of the EU’s Medical Device and IVD Regulation. Its concrete proposals address multiple concerns.

German Row Over Classification Of Telemonitoring Software Looks Set To Rumble On

When does an app qualify as a medical device and when does it not? A German court case appears to have wider-reaching implications for medtech than might first appear.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT145918

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel